HSBC HOLDINGS PLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 319 filers reported holding IMMUNOMEDICS INC in Q2 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$2,199,000
+797.6%
25,852
+273.6%
0.00%
Q2 2020$245,000
-39.2%
6,920
-63.1%
0.00%
-100.0%
Q4 2019$403,000
+550.0%
18,761
+11.8%
0.00%
Q4 2016$62,00016,7810.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 4,750,000$112,433,00020.02%
Avoro Capital Advisors LLC 17,714,461$419,301,00016.14%
Foresite Capital Management III, LLC 2,541,729$60,163,00012.96%
Foresite Capital Management IV, LLC 1,231,543$29,151,0009.94%
Ghost Tree Capital, LLC 1,250,000$29,588,0008.71%
NEXTHERA CAPITAL LP 1,329,104$31,460,0004.87%
RA Capital Management 3,119,778$73,845,0004.79%
DLD Asset Management, LP 2,682,100$63,458,0004.78%
Palo Alto Investors LP 4,803,364$113,696,0004.54%
DLD Asset Management, LP 2,411,600$57,058,0004.30%
View complete list of IMMUNOMEDICS INC shareholders